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Abstract
Drug-induced anaphylaxis (DIA) is a highly paradoxical disorder involving a fatal response to medicines prescribed for therapeutic
purposes. This study aimed to improve the awareness on DIA and to prevent errors through an analysis of lawsuit judgments.
Sentenced judgments involving DIA from 1998 to 2017 using the database of the Korean Supreme Court Judgment System were
collected. General characteristics, results, and recognized negligence of DIA litigation cases were analyzed.
Of 27 lawsuit cases included, antibiotics (n=6, 22.2%), radiocontrast media (n=6, 22.2%), and non-steroidal anti-inﬂammatory
drugs (n=5, 18.5%) were the most common drugs that had caused DIA. Cardiac arrest was reported in 23 cases (85.2%). The
median time interval from drug administration to diagnosis and from diagnosis to cardiac arrest were 7 (interquartile range, IQR=0–
35) and 5 minutes (IQR=0–33), respectively, suggesting insufﬁcient time to cope with anaphylaxis. Consequently, either death (n=
18, 66.7%) or ischemic brain injury (n=9, 33.3%) occurred in all cases. Violation of duty of care was recognized in 19 cases (70.4%)
with median awarded amount of $106,060 (IQR=$70,296–$168,363). The recognized negligence included inadequate observation
after drug administration (n=6), delayed or missed epinephrine administration (n=6), ignoring a history of allergy or drug
hypersensitivity (n=6), and prescription error (n=5).
It is necessary to improve the awareness on DIA, because making a trivial error in any process of history taking, drug prescription
and administration, observation, and/or emergency treatment may have fatal consequences that can lead to indemnity.
Abbreviations: CPR = cardiopulmonary resuscitation, CT = computed tomography, DIA = drug-induced anaphylaxis, IQR =
interquartile range, IRB = institutional review board, KRW = Korean Won, NSAIDs = non-steroidal anti-inﬂammatory drugs, USD =
United States Dollars.
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11. Introduction
Drug-induced anaphylaxis (DIA) is a highly paradoxical disorder
in which therapeutic medications become fatal agents. Although
little is knownabout the epidemiologyofDIA, the incidenceofDIA
has been estimated to be 0.04% to 3.1%,[1,2] and is responsible for
one case in every 4000 emergency department visits.[3] However,
other studies have reported increasing frequency and severity of
DIA.[4–6] Moreover, DIA is likely to be more severe and fatal than
anaphylaxis causedbyother factors,[6] and accounts forup to58%
of fatal anaphylaxis.[6,7]
Despite its increasing frequency, severity, and fatality, physi-
ciansmaybe insufﬁciently awareofDIAdue to its low frequency.[8]
In addition, the patient and caregivers may have insufﬁcient
understanding of the sudden and fatal characteristics of DIA,
which possibly leads to medical disputes. Although anaphylaxis is
mainly caused by an individual’s unique immunity, and is not
induced intentionally by the physician, this unexpected situation
may make the patient and caregivers initially suspect that the
physician is at fault.
The analysis of medical lawsuit judgment is helpful for the
identiﬁcation and prevention of malpractice based on actual
cases. However, there is no precedent in lawsuit judgment
analysis studies to prevent malpractice associated with DIA.
Therefore, this study performed analyses of lawsuit judgments,
including presenting descriptive clinical features, culprit drugs,
and physician’s negligence as recognized by the court. Finally, we
Hyeon et al. Medicine (2019) 98:23 Medicineaimed to improve the awareness on DIA and to prevent errors
that may lead to a critical outcome.2. Materials and methods
2.1. Judgment collection
In this retrospective study, we searched for all medical civil
litigation cases sentenced from January 1, 1998 to December 31,
2017 with the term “anaphylaxis” using the database of the
Korean Supreme Court Judgment System.[9] We found 107
judgments, which were reviewed to extract anaphylactic events
after drug administration. Cases were excluded if anaphylaxis
was caused by other factors such as food or bee stings, or if the
court judged the case as resulting from factors other than
anaphylaxis, such as a side effect from a pharmacologic action or
a severe cutaneous adverse reaction. The personal information on
judgments is anonymized by the Court, and the database we used
is accessible by any individual.Table 1
General characteristics of cases (n=27).
Age (yr)
< 19 4 (14.8%)
19–60 12 (44.4%)
> 60 3 (11.1%)
Not descripted 8 (29.7%)
Sex
Male 12 (44.4%)
Female 13 (48.1%)
Not described 2 (7.4%)
Positive past history of allergy or drug hypersensitivity 7 (25.9%)
∗
Drug hypersensitivity† 4
Asthma 2
Atopic dermatitis 1
Allergic rhinitis 1
Unspeciﬁed allergy 1
Data are shown as number or number (%).
∗
The sum of the details exceeds the total number because one patient had a history of both allergic
rhinitis and atopic dermatitis and another patient had a history of both asthma and aspirin
hypersensitivity.
† Aspirin, non-steroidal anti-inﬂammatory drug, ranitidine, and hydrocortisone were causative drugs in
the past history, respectively.2.2. Clinical information on the judgments
Based on the description of the judgment texts, information on age
and sexof the patient, historyof allergyor drughypersensitivity, and
the culprit drug along with route of administration were collected.
Data concerning the defendants such as the type of institution and
medical specialty of the physician were also collected. According to
the World Allergy Organization Guidelines for the Assessment and
Management of Anaphylaxis,[10,11] the symptoms of anaphylaxis
described in the judgment textswerealsocollectedand classiﬁed into
5 groups: mucocutaneous, respiratory, gastrointestinal, cardiovas-
cular, and neurologic symptoms. Furthermore, data regarding the
time frame of the symptoms described, and time intervals between
drug administration and the diagnosable time point for anaphylaxis
were collected andanalyzed.Diagnosable timepoint is deﬁnedas the
pointatwhichdiagnosis criteriaweremetbasedon the symptomand
time frame described in the judgment texts. For cases involving
cardiac arrest, data regarding the time intervals between the
diagnosable timepoint andcardiac arrestwere additionally collected
and analyzed. Information about the ﬁnal statuses of patients after
anaphylaxis attack was also collected.
2.3. Judicial decision
In terms of judgment, data regarding the progress of litigation,
whether theplaintiff prevailed, and theamounts claimedandawarded
for damage were also collected (the exchange rate was converted to 1
United States Dollar (USD)=1,100KoreanWon (KRW) considering
the mean exchange rate for 2018). Finally, we collected and analyzed
the court rulings regarding whether physicians were negligent and
violated their duty of care during the process of history taking, drug
prescription and administration, observation, and emergency
treatment. Among dismissed cases, we attempted to identify any
measures to prevent malpractice by presenting some example cases
and comparing the reasons for dismissal.
2.4. Statistical analysis
Categorical variables are presented as absolute frequencies with
number and relative frequencies with percentages. Continuous
variables, such as time intervals and the amounts claimed and
awarded for damage, were assessed using the Shapiro-Wilk test to
determine its distribution (considered as non-normal distribution2if P< .05).[12] Average and standard deviation (normal distribu-
tion), or median and interquartile range (non-normal distribu-
tion) were reported as appropriate. Statistical analyses were
performed with SPSS 24 (IBM, Armonk, NY).2.5. Ethics statement
Institutional Review Board (IRB) approval was not necessary in
this study. This study was based on the sentenced lawsuit
judgments which are publicly accessible by any individual in the
database of the Korean Supreme Court Judgment System. In
addition, each court provided the researcher with the judgments
after deleting personally identiﬁable information; thus, access to
sensitive personal information was impossible. This study was an
analysis of medical lawsuit judgments that had already been
adjudicated and did not include any infringement or threat of
patients’ rights.3. Results
3.1. General characteristics
A total of 27 DIA-related litigation cases (53 judgments) were
ﬁnally analyzed. General clinical characteristics such as age, sex,
and past history of allergy or drug hypersensitivity are presented
in Table 1. Anaphylaxis lawsuits occurred irrespective of the size
of hospitals, that is, primary clinics, district hospitals, and tertiary
hospitals. In terms of medical specialty, internal medicine,
emergency medicine, and pediatrics were the most common with
3 cases each. However, other medical specialties were also subject
to lawsuits (Fig. 1).
3.2. Culprit drugs and administration route
Antibiotics (n=6, 22.2%), radiocontrast media (n=6, 22.2%),
and non-steroidal anti-inﬂammatory drugs (NSAIDs) (n=5,
18.5%) were the most common culprits. Other culprit drugs were
lidocaine, H2 blocker, opioids, Picibanil (Lyophilized mixture of
low-virulence Streptococcus pyogenes and a high content of
Primary clinic 
30% 
District 
hospital 
18% 
Tertiary 
hospital 
48% 
Not 
described 
4%  
Institution types of defendants 
Internal medicine 
11% 
Emergency 
medicine 
11% 
Pediatrics 
11% 
Obstetrics and 
gynecology 
8% 
Otolaryngology 
7% Plastic surgery 
7% 
General surgery 
7% 
Urology 
4% 
Thoracic surgery 
4% 
Orthopedics 
4% 
Not described 
26%
Types of medical specialty A                                                                                                       B
Figure 1. (a) The types of medical institutions and (b) medical specialties of the defendants.
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sone. The most common route of administration was intravenous
(n=16, 59.2%), followed by intramuscular (n=4, 14.8%),
subcutaneous (n=2, 7.4%), and oral (n=2, 7.4%). (Table 2)Table 2
Culprit drugs and the administration route.
Culprit drugs
Antibiotics 6 (22.2%)
Radiocontrast media 6 (22.2%)
NSAIDs 5 (18.5%)
Others 6 (22.2%)
Lidocaine 2
Ranitidine 1
Pentazocine 1
Hydrocortisone 1
Picibanil 1
Undeterminable as single agent 4 (14.8%)
Tramadol and ranitidine 1
Ketamine and propofol 1
Talniﬂumate and eperisone 1
Cephalosporin and sulpyrine 1
Administration route
Intravenous 16 (59.2%)
Intramuscular 4 (14.8%)
Subcutaneous 2 (7.4%)
Oral 2 (7.4%)
Intrapleural (for pleurodesis) 1 (3.7%)
Intravenous and/or intramuscular
(undeterminable as single agent)
1 (3.7%)
Not described 1 (3.7%)
Data are shown as number or number (%).
NSAIDs=non-steroidal anti-inﬂammatory drugs.
33.3. Symptom presentation
A summary of symptom presentation is shown in Table 3. Only
29.6% of cases (n=8) had mucocutaneous symptoms. In
contrast, the frequency of respiratory (n=20, 74.1%), cardio-
vascular (n=25, 92.6%) and neurologic symptoms (n=19,
70.3%) were higher.
Twelve (44.4%) of 27 cases were diagnosable as anaphylaxis
within 10 minutes after administering the culprit drugs; 6 were
diagnosed immediately after administration. After excluding
cases with missing information, the median time interval between
drug administration and diagnosable time point were 7 minutes.
Progression to cardiac arrest was observed in 23 cases
(85.2%). Among them, 12 cases had a diagnosable time pointTable 3
Clinical presentation of anaphylaxis on lawsuits.
Incidence of presented symptoms
Mucocutaneous 8 (29.6%)
Respiratory 20 (74.1%)
Gastrointestinal 9 (33.3%)
Cardiovascular 25 (92.6%)
Neurologic 19 (70.3%)
Accompanied cardiac arrest 23 (85.2%)
Result of anaphylaxis
Death 18 (66.7%)
Ischemic brain injury 9 (33.3%)
Time intervals – median (IQR) minutes
From administration of the culprit drug
to diagnosable time point of anaphylaxis
7 (0–35)
From diagnosable time point of anaphylaxis
to cardiac arrest
5 (0–33)
Data are presented as number, number (%), median (interquartile range).
IQR = interquartile range.
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with cardiac arrest. Cardiac arrest occurred almost immediately
after administering the culprit drug in 2 cases; here, the median
time interval from the diagnosable time point to cardiac arrest
were 5 minutes after excluding cases with missing information.
As a result of anaphylaxis, 18 patients (66.7%) died. The other 9
patients (33.3%) experienced ischemic brain injury.
Both time intervals are presented as median with interquartile
range in Table 3 as it showed non-normal distribution (both
P< .01). The distribution of each time interval is shown in Fig. 2.
3.4. Judgment status
Violations of the physician’s duty of care were recognized in 19
(70.4%) of the 27 cases. A summary of judgment statuses is
shown in Table 4. Amount for damages of both claimed and
awarded are presented as median with interquartile range, as it
showed non-normal distribution (both P< .01).3.5. Physician’s negligence recognized by the courts
Events of negligence during the process of history taking, drug
prescription and administration, observation, and emergency
treatment of anaphylaxis were classiﬁable into 8 groups. The
frequencies of each class of negligence are shown in Fig. 3.
3.6. Inadequate observation
It was pointed out in 6 cases. In 2, anaphylaxis occurred after
discharge without appropriate observation after the administra-
tion of the culprit drug in outpatient clinics. In another in-patient
case, there was no observation period following drug adminis-
tration, and the patient was found in a state of anaphylaxis after 5
minutes. Despite treatment with epinephrine and intubation
within 5 minutes of discovery, the case was recognized as
negligence. In the other 2 cases, failure to contact a physician
leading to delayed treatment, was the source of negligence (29
and 33minutes, respectively). In the remaining case, although the
caregiver informed the radiology technician that the patient
began coughing after the administration of the radiocontrast
media for computed tomography (CT) scan, no one took notice; a
subsequently notiﬁed physician prescribed steroid and antihista-
mine without visiting the patient. The patient developed cardiac
arrest within a few minutes. This event was recognized as
negligence due to inadequate observation, while another case
where a nurse observed the patient for 5 minutes after drug
injection and left the patient after conﬁrming that the caregiver
remained by the patient’s bedside was not recognized as
negligence.3.7. Delayed or missed epinephrine administration
Six cases were categorized in this group. In 4 cases of delayed
administration, time intervals between onset of anaphylaxis and
epinephrine administration were 19, 20, 97, and 114 minutes,
respectively. In the ﬁrst case involving a 19-minute delay, this
interval was recognized as negligence, although other procedures,
such as tracheal intubation, had been performed promptly. In
contrast, a 6-minute delay in the ﬁrst epinephrine administration
was not recognized as negligent. In 2 missed cases, epinephrine
was not administered in the defendant’s institution, but was
administered after transfer to a higher hospital. This was4recognized as negligence even though the setting was a primary
clinic.3.8. Ignoring a history of allergy or drug hypersensitivity
Six cases were classiﬁed in this group. In 4 cases, despite the
existence of related medical records, known cross-reacting drugs
or the same culprit drugs were prescribed. The fact that the
patients did not inform hospital staff about their drug allergy/
hypersensitivity history at the time of drug administration did not
affect the court’s decision of physician negligence. In the other 2
cases, physicians did not ask the patient’s past drug allergy/
hypersensitivity history.3.9. Prescription error (contraindication, dosage, and
timing, route, and rate of administration)
Five cases fell in this category. In 2 cases, sulpyrine, which is
contraindicated in persons under 12 years of age, was
administered to children. The court pointed out in both cases
that the physician prescribed sulpyrine without serious consid-
eration of the associated side-effects and risks for persons less
than 12 years of age. Furthermore, the court quoted that previous
studies had not established the safety and efﬁcacy of sulpyrine in
children younger than 14 years and that the frequency of
sulpyrine-associated anaphylaxis is relatively high, at 1 in every
5000 injections. One case of anaphylaxis resulted from incorrect
dosage. The patient, who had hypersensitivity reactions during
the initiation of anti-tuberculous medication, received a prescrip-
tion of rifampin specifying a regular dose, which resulted in
anaphylaxis. The court commented that the drug had caused a
hypersensitivity reaction and should have been initiated at a
lower dose, with gradual dose escalation in order to prevent
anaphylaxis. Another case of anaphylaxis resulted from incorrect
timing of administration. Cephalosporin (unspeciﬁed) was
administered to a pregnant woman as a prophylactic antibiotic
before delivery, rather than after delivery. It caused anaphylaxis
of the newborn in the mother’s body and led to death. In another
case, the prescription order regarding the route of administration
and injection rate of aspirin lysine were noted as negligence. The
court determined that the order had been made without carefully
considering the route of administration based on the fact that the
intravenous administration of aspirin is only indicated when oral
administration is impossible or has an insufﬁcient therapeutic
effect. In addition, the physician did not give speciﬁc instructions
other than to slowly administer the injection, and the drug was
delivered as bolus injection.3.10. Delayed or inappropriate airway management
Four cases fell in this group. To determine whether the physician
violated their duty of care due to non-performed or a delay in
performing intubation, the court considered medical circum-
stances at that time rather than recognizing it as negligence
unconditionally. For example, there was 1 case with a dismissed
claim in which airway management consisted of just securing the
airway and performing mouth-to-mouth breathing at a primary
outpatient clinic (specialty unspeciﬁed). However, this aspect is
judged more strictly in a setting capable of tracheal intubation. In
a primary plastic surgery clinic, which would presumably be
equipped with an operating room, a faulty intubation itself was
recognized as negligent, despite the clinicians’ efforts. In addition,
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Figure 2. (a) Time interval from drug administration to diagnosable time point of anaphylaxis based on described symptoms (n=27) and (b) time interval from
diagnosable time point to cardiac arrest (n=23).
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Table 4
Judgment status.
Litigation progress
First trial 13 (48.1%)
Appeal 5 (18.5%)
Supreme court 9 (33.3%)
Violations of physician’s duty of care 19 (70.4%)
Amount for damage – median USD (IQR)
Claimed 269,277 (173,545–563,131)
Awarded (in cases of violation of duty of care) 106,060 (70,296–168,363)
Data are presented as number (%), median (interquartile range).
USD = United States Dollar; the exchange rate was 1 United States Dollar (USD)=1100 Korean Won
(KRW), IQR = interquartile range.
Hyeon et al. Medicine (2019) 98:23 Medicine10- and 17-minute delays in intubation in an emergency room
setting were recognized as negligent events. Particularly, the court
noted that in the case of the 10-minute delay, intubation should
have been performed immediately if the airway could not
adequately be secured. Although ambu-bagging had been
performed before tracheal intubation, the court recognized that
this procedure was not helpful, based on the poor results from a
follow-up arterial blood gas analysis.3.11. Delayed or inappropriate cardiopulmonary
resuscitation (CPR)
Four cases were recognized as improper CPR performance. In 3
cases, it was pointed out that the CPR should have begun
immediately. The reasons for delaying CPR included a delay
because of intubation, a failure to recognize to begin CPR until
the arrival of emergency service, and a delay from failing to
contact the physician without any other actions performed for 33
minutes. In the remaining case, errors in CPR performance were
pointed out and included performing chest compressions several
times with interruptions and performing a digital rectalInadequate preparation of emergency eq
Missed 
Delayed or inappropri
Delayed or inappropriate airway mana
Prescrption error  (contraindication, dosage, administration timing, route a
Ignoring a history of allergy or drug hyperse
Missed or delayed epinephrine admin
Inadequate obs
Figure 3. Court recognition of a physician’s negl
6examination during CPR. The defendant claimed that the reason
for the unprofessional-looking CPR was that the vital signs
ﬂuctuated. However, this claim was dismissed based on the
submitted medical records, which revealed that the reactive
changes in vital signs and electrocardiography readings had not
been recorded faithfully.3.12. Missed skin test
There were 2 cases with Picibanil and cefotaxime as culprit drugs,
and both were recognized as negligence due to skipping a skin
test. The court cited information about each drug from the
pharmacopoeia, which states that a skin test is desirable before
administration. Seven cases were dismissed on this point, because
the circumstances in which the skin test was performed were
either acceptable or the skin test was not an essential process.
Remarkably, there was an inconsistency between judgments of
using a skin test for testing allergy/sensitivity to cephalosporin.
The former case of cefotaxime was concluded in 2005, while
another more recent case of cefotetan was dismissed in the
Supreme Court in 2017. In the latter case, the court cited the fact
that the effectiveness of skin tests, except for penicillin, remains
unclear, and a number of institutions do not perform skin tests
for patients who do not have a history of cephalosporin
hypersensitivity.3.13. Inadequate preparation of emergency equipment
Two cases were identiﬁed in this group. Both cases pointed out
that despite the possibility of hypersensitivity, administration of
the culprit drugs was performed in an unprotected setting
without appropriate emergency equipment. As a result, the
hypoxic brain damage was attributed to prolonged hypoxia
while transferring the patient to the emergency room. In contrast,
there was a case in which this form of negligence was dismissed
because the distance between the CT room and the emergency0% 20% 40% 60% 80% 100% 
uipment 
skin test 
ate CPR 
gement 
nd rate) 
nsitivity 
istration 
ervation 
Percentage of malpractice cases 
igence or violation of the duty of care (n=19).
Hyeon et al. Medicine (2019) 98:23 www.md-journal.comroom was only 10 m, which was recognized sufﬁciently close to
enable prompt ﬁrst aid.4. Discussion
4.1. Culprit drugs
Previous studies have shown that antibiotics, NSAIDs, anes-
thetics, radiocontrast media, anti-neoplastic agents and biologic
agents are the main culprit of DIA in general.[13–19] In this study,
antibiotics, radiocontrast media, and NSAIDs were the most
common causes of DIA-related litigations. In contrast, in an
anaphylaxis-related malpractice litigation study (2011–2016)
published in the United States in 2018, CT radiocontrast media
was the most commonly implicated allergen, accounting for 40%
of the total cases.[20] However, in principle, all drugs may induce
anaphylaxis. Considering that, there was a case of hydrocorti-
sone, even an agent for allergy treatment, the possibility of DIA
should be considered in all prescriptions.4.2. Prescription and drug administration
History taking is one of the most important measures to prevent
DIA. Therefore, past history should be taken seriously. It should
be recorded in a prominent area so that it can be shared with
other medical staff. For a patient with a history of allergy or drug
hypersensitivity, it is advisable to notify medical staff about their
history repetitively. It is worthy to note that the most common
malpractice causing anaphylaxis-related litigation in the United
States is re-exposure to known allergens.[20]
In terms of skin test, previous studies have demonstrated a poor
predictive value for radiocontrast media and antibiotics[21–24]
except penicillin[25]. In addition, no standardized method has
been established, and the sensitivity and speciﬁcity for such
antibiotics (except for penicillin) has not been clariﬁed. The more
recent judgement regarding cefotetan suggests that the court also
recognizes this practice.
If a physician does not follow the directions such as
contraindication, dosage, or administration, it might be recog-
nized as negligence. Therefore, the reason for going against the
directions should be clariﬁed and risk-beneﬁt should be carefully
considered. Particularly, for sulpyrine, which is contraindicated
in children, efforts should be made to use other drugs with
sufﬁcient safety for children. Regarding the judgment related to
the route and rate, the facts quoted by the court are also
conﬁrmed in the pharmacopoeia. Therefore, when prescribing a
drug, it is preferable to consider information such as what is
described in the pharmacopoeia prior to prescription, considering
that the route or rate of administration may also be a problem.4.3. Adequate observation and prompt recognition of
anaphylaxis
Although mucocutaneous symptoms are reported in 80% to
90% of cases of anaphylaxis in general,[10,11] only about 30% of
the DIA litigation cases in our study involved mucocutaneous
symptoms, suggesting that in many cases reaching the diagnosis
of anaphylaxis were relatively difﬁcult.[26–29] In contrast,
although cardiovascular symptoms are reported in up to 45%
of cases of anaphylaxis,[7] more than 90% of cases in this study
involved cardiovascular symptoms, and most cases were
accompanied by cardiac arrest. Neurologic symptoms were also7recognized more frequently in this study than in previous reports
(up to 15%).[10,11] This discrepancy is likely due to the
occurrence of end-organ dysfunction, as indicated by the
pathophysiology resulting from decreased cerebral blood
ﬂow.[27] In addition, many cases progressed rapidly, suggesting
that there might have been insufﬁcient time to cope with the
emergency. Therefore, when a drug, which can cause anaphylaxis
is administered, careful observation is required after administra-
tion and even atypical presentations should be recognized
promptly. However, there are no speciﬁed guidelines regarding
how long this observation should continue after administration.
Thus, speciﬁed suggestions regarding observation times should
be presented.
Additionally, considering the negligence cases due to inappro-
priate emergency kit preparation, prompt access to epinephrine
and airway management equipment should be available when
administering a drug that can cause anaphylaxis. Finally, medical
personnel should remember that inadequate observation and
non-preparation of an emergency kit may result in failure of a
prompt response to DIA.4.4. Prompt and appropriate management of anaphylaxis
Early epinephrine treatment has been reported to reduce
mortality and hospitalization rates and to improve the clinical
prognosis of anaphylaxis.[11] However, several studies have
shown that epinephrine is administered in as low as 24% to 30%
of cases,[30,31] and close to one third of physician’s are not aware
of the usage of epinephrine.[32] Therefore, emphasis should be put
on improving the awareness of medical staff on the ways to use
this most important therapeutic entity. Even in a primary clinic,
epinephrine should be available. Additionally, physicians need to
make timely and early efforts to administer epinephrine in cases
of DIA to prevent further signiﬁcant morbidity.
Prompt airway management is also important. In a primary
clinic, securing the airway and mouth-to-mouth breathing or
ambu-bagging should at least be performed.Where an immediate
tracheal intubation is expected to be possible (emergency room,
operation room, or an inpatient ward), securing the airway
should not be delayed without justiﬁed reasons. If intubation fails
for reasons such as severe laryngeal edema, othermethods such as
cricothyroidotomy should be used to secure the airway.[33]
Cardiac arrest should be detected promptly, and chest
compression (the most important step in resuscitation) should
be performed immediately and correctly. It should not be delayed
for any reason, even for tracheal intubation. The meticulous
maintenance of medical records related to the emergency is also
critical, considering that the court deemed CPR to have been
inappropriate because of poor medical records regarding the
course of treatment and changes in the patient’s status.4.5. Limitation
This study has several limitations. First, the number of cases
included in the study was small. This is because not all medical
disputes proceed to litigation. In the settlement process of
disputes, there are solutions such as agreement or arbitration
before litigation, and only a few disputes eventually proceed to
litigation. Second, the clinical features described in this studymay
not represent the general features of DIA because of selectivity
bias from litigation. Third, information that might be needed for
analysis was missing because information was collected based
Hyeon et al. Medicine (2019) 98:23 Medicineonly on anonymized sentenced judgments, in a few cases. Fourth,
judges, not medical professionals wrote the contents of the
judgment. Therefore, it is difﬁcult to conclude that the facts
described in the judgments are completely objective medical facts.
Fifth, the analysis period is 20 years, which may be difﬁcult to
fully reﬂect the rapidly changing current medical environments.
For example, sulpyrine (one of the causative agents in this study)
has been withdrawn from the Korean market due to the known
risks such as anaphylaxis and agranulocytosis since 2004.
However, the basic treatment of anaphylaxis such as epinephrine
and proper airwaymanagement has not changed. In addition, the
grounds for judging malpractice, even 20 years ago, are still
worthy of reference.
Despite several limitations, this study is expected to play an
important role in improving the awareness on DIA that any
physicians may encounter incidentally.5. Conclusion
Considering that there were many atypical presentations without
mucocutaneous symptom in lawsuit cases of DIA, physicians
should be familiar with the diagnostic criteria of anaphylaxis and
should not miss even atypical presentation. Also, since the
progression showed rapid and fatal, medical institutions and the
staff should be able to respond to DIA promptly. Even only 1
error during the process of history taking, drug prescription and
administration, observation, and emergency treatment may lead
to fatal consequences and indemnity. Therefore, it is important
not to repeat the malpractice conﬁrmed in this study, especially
when prescribing drugs well-known to induce DIA. In this way,
this study will help improve awareness regarding DIA and
prevent related malpractice.Author contributions
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